A laboratory model for Sjögren's syndrome.

The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol (1972) 2.01

Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren's syndrome. J Clin Invest (1970) 1.44

Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome. Invest Ophthalmol Vis Sci (2001) 1.22

Sjögren's syndrome: studying the disease in mice. Arthritis Res Ther (2011) 1.21

Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis. Am J Pathol (1999) 1.11

Current concepts: mouse models of Sjögren's syndrome. J Biomed Biotechnol (2010) 1.06

Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice. Clin Exp Immunol (1989) 1.05

Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease. Oral Dis (2011) 1.05

Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J Clin Invest (1998) 1.02

Monoclonal macroglobulinemia in NZB-NZW F1 mice. J Exp Med (1973) 1.02

Immunologic studies of autoimmune disease in NZB-NZW F1 mice. I. Binding of fluorescein-labeled antinucleoside antibodies in lesions of lupus-like nephritis. J Exp Med (1969) 1.01

Genes and Sjögren's syndrome. Rheum Dis Clin North Am (2008) 1.01

Mononuclear cell pulmonary vasculitis in NZB/W mice. II. Immunohistochemical characterization of the infiltrating cells. Am J Pathol (1986) 0.89

NaCl-preferring NZB/B1NJ mice and NaCl-avoiding CBA/J mice have similar amiloride inhibition of chorda tympani responses to NaCl. Chem Senses (1998) 0.89

Induction of experimental allergic sialadenitis in mice. Am J Pathol (1985) 0.88

Effect of nandrolone decanoate on Sjögren's syndrome like disorders in NZB/NZW mice. Clin Exp Immunol (1984) 0.86

Spontaneous development of autoimmune sialadenitis in aging BDF1 mice. Am J Pathol (1988) 0.83

Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome. Ann Rheum Dis (2003) 0.82

Immunopathology of experimental autoallergic sialadenitis in C3H/He mice. Clin Exp Immunol (1989) 0.79

Association of Sjögren's syndrome with C4 deficiency, defective reticuloendothelial function and circulating immune complexes. Clin Exp Immunol (1983) 0.77

Sjögren syndrome: what and where are we looking for? Curr Opin Ophthalmol (2015) 0.75

Therapeutic effects of nandrolone decanoate, tibolone, lynestrenol and ethylestrenol on Sjögren's syndrome-like disorder in NZB/W mice. Clin Exp Immunol (1986) 0.75

Association of interstitial nephritis with tubule cell injury and proliferation in NZB/NZW mice. Clin Exp Immunol (1978) 0.75

Effect of low dietary lipid on the development of Sjögren's syndrome and haematological abnormalities in (NZB x NZW)F1 mice. Ann Rheum Dis (1989) 0.75

Systemic lupus erythematosus, Sjögren's syndrome and glomerular nephritis. Postgrad Med J (1977) 0.75

THE NATURAL HISTORY OF AUTOIMMUNE DISEASE IN NZB MICE. A COMPARISON WITH THE PATTERN OF HUMAN AUTOIMMUNE MANIFESTATIONS. Ann Intern Med (1963) 4.22

A clinicopathologic study of Mikulicz's disease. Am J Pathol (1953) 3.17

Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med (1967) 2.92

Benign lymphoepithelial lesion of the parotid gland adenolymphoma, chronic inflammation, lymphoepithelioma, lymphocytic tumor, Mikulicz disease. Cancer (1952) 2.50

A stable starch substrate for the determination of amylase in serum and other body fluids. Am J Clin Pathol (1959) 1.72

Sjögren's syndrome. Bull Rheum Dis (1966) 1.41

NZB/NZW mice as a model of systemic lupus erythematosus. JAMA (1966) 1.39

Age changes in the parotid glands of Wistar Institute rats with special reference to the occurrence of oncocytes in senility. Am J Anat (1949) 1.30

CLINICAL, PATHOLOGIC, AND SEROLOGIC STUDIES IN SJOEGREN'S SYNDROME; COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. Ann Intern Med (1964) 1.06

Organ antibodies in disseminated lupus erythematosus. Acta Med Scand (1965) 1.06

Impact of screening for mental health concerns on health service utilization and functional status in primary care patients. Arch Intern Med (1997) 1.00

Eye changes in autoimmune NZB and NZB x NZW mice. Comparison with Sjögren's syndrome. Arch Ophthalmol (1971) 0.78

Hyperglycemia in the NZB/NZW F1 hybrid mouse. Anat Rec (1975) 0.75